ORTHOCELL LTD

ASX: OCC (ORTHOCELL FPO [OCC])

Last update: 21 Dec, 2024, 6:34PM

1.24

-0.01 (-0.80%)

Previous Close 1.25
Open 1.26
Volume 1,745,740
Avg. Volume (3M) 1,231,123
Market Cap 297,231,744
Price / Sales 51.50
Price / Book 71.66
52 Weeks Range
0.350 (-71%) — 1.27 (2%)
Earnings Date 21 Feb 2025 - 25 Feb 2025
Profit Margin -135.10%
Operating Margin (TTM) -140.87%
Diluted EPS (TTM) -0.040
Quarterly Revenue Growth (YOY) 15.10%
Total Debt/Equity (MRQ) 15.22%
Current Ratio (MRQ) 4.34
Operating Cash Flow (TTM) -6.51 M
Levered Free Cash Flow (TTM) -4.91 M
Return on Assets (TTM) -25.04%
Return on Equity (TTM) -134.46%

Market Trend

Short Term Medium Term
Industry Biotechnology (AU) Mixed Mixed
Biotechnology (Global) Mixed Mixed
Stock ORTHOCELL FPO [OCC] - -

AIStockmoo Score

0.3
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -3.0
Technical Moving Averages 0.0
Technical Oscillators 4.0
Average 0.25

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
OCC 297 M - - 71.66
NEU 2 B - 12.75 4.48
BOT 818 M - - 7.49
PYC 747 M - - 8.70
CUV 601 M 0.40% 17.14 2.99
IMM 342 M - - 2.76

Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialization of biological medical devices, cell therapies, and related technologies to address unmet clinical needs in human health in the regenerative medicine industry. Its product includes Striate plus; Remplir which is a collagen wrap used in peripheral nerve repair; and OrthoACI an implantation used for the treatment of articular cartilage defects in the knee and ankle. It also has various other products in its pipeline such as Tendon Cell Therapy and Collagen Medical Device Platform.

Sector Healthcare
Industry Biotechnology
Investment Style Small Growth
% Held by Insiders 21.75%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria